Markets — Fundexpressone

Oil Price Drops No Longer Pulling Treasury Yields Lower

The historic link between oil prices and Treasury yields is fracturing, signaling inflation fears have spread well beyond energy costs.

Shifting rate outlooks drive divergent moves in technology and banking equities, creating strategic considerations for investors.

Rockrose is pursuing a $300 million commercial mortgage-backed securities deal that includes a Sierra tenant, according to Bloomberg.

October CPI data and a wave of Fed speakers could challenge the broadening stock rally that has moved past mega-cap technology stocks.

History suggests the bond market's prolonged weakness could precede a major turnaround, offering a cautionary note for pessimistic investors.

Crude oil fell at the open after President Trump suggested fresh U.S. attacks on Iran are unlikely, easing geopolitical risk premiums.

Nvidia's board has opened a probe into CEO Jensen Huang's relationship with an alleged spy, though Huang will stay in his role during the review.

Stock correlations hit a record low, and a reversion to the mean could spell fresh trouble for equities.

Procter & Gamble SVP Matthew Janzaruk disclosed a share sale valued at approximately $1.55 million, according to a regulatory filing.

Researchers flagged well-timed wagers on two Senate races placed before a Times/Siena poll dropped, raising questions about possible insider access.

The S&P 500 is far less diversified than many investors assume, with heavy AI-sector exposure creating potential vulnerability.

Civeo's chief executive offloaded shares worth over $865,000, a transaction that draws routine scrutiny from investors monitoring insider activity.

Big Tech shares have pulled back, leaving investors weighing their next moves. Weekend reads offer guidance on income, taxes, and home buying.

Micron's low valuation is drawing attention, but investors disagree sharply on whether its earnings power can sustain the apparent bargain.

DraftKings shares tumbled sharply Friday as analysts flagged regulatory risks and rising competition tied to its prediction market push.